2,364
Views
4
CrossRef citations to date
0
Altmetric
Diabetes

Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitus

, , , , , , , , & ORCID Icon show all
Pages 1277-1284 | Received 01 Nov 2019, Accepted 23 Mar 2020, Published online: 13 May 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.